According to a report published by Insure Insights, the global facial injectable products are estimated to grow at a CAGR of 30.2% during the forecast period. Facial injectable products, also known as dermal fillers, are products that help in bio-engineering or facial rejuvenation. As the age grows, the facial skin loses subcutaneous fat, and the skin is pulled closer to the facial working muscles hence smile lines and wrinkles over the face become more visible. This also leads to the stretching of facial skin, which adds to the loss of volume. These issues can be solved by using facial injectables or dermal fillers as these products help in treating early signs of aging or adding value to a facial rejuvenation surgery. The growing demand for minimally invasive surgeries on account of their swift wound healing property and visible effects of treatment are spurring the market growth.

Top Driver: Technological Advancements and Associated Benefits

Technological advancements in procedures and products and variations in demographics of the patient are encouraging physicians and dermatologists to treat several facial areas. These advancements assist physicians or dermatologists in designing upgraded treatment for users and enable the implementation of combination goods to get optimized results and drive the global facial injectables market. All these factors are expected to help in the growth of the market in the future. Amplified goods such as HA (Hyaluronic Acid) and BoNTA (Botulinum Toxin Type A) fillers are integrated to enhance results, specifically in the lower face processes. This stimulates the global facial injectables market growth as well. HA fillers are typically preferred by physicians owing to their improved acceptance, biodegradable nature, and high viscosity, as well as for the durability they offer to the restored volume. This is also one of the factors responsible for the growth of the global facial injectables market.

Hyaluronic Segment is Estimated to Witness Significant Growth During the Forecast Period

The facial injectable market has been segmented into collagen, hyaluronic acid, botulinum toxin type A, calcium hydroxylapatite, and polymer fillers based on the product. The hyaluronic acid segment dominates the market and is expected to witness significant growth during the forecast period. The expanding application of hyaluronic acid in the cosmetic industry is expected to fuel growth. Hyaluronic acid has become a significant part of cosmetics due to its strong water retention properties and non-allergic reactions. In addition, cosmetic-grade hyaluronic acid has a low molecular weight that enables deep penetration of the product in the skin, helps retain water in the cells, releases antioxidants, and delays the aging process, thus propelling the market demand. On the basis of application, the market is segmented into therapeutics and aesthetics.

  Increasing Geriatric Population and Growing Beauty Concern to Benefit North America Market

North America is the dominating region in the global facial injectables. The growth is attributed to the increase in the expenditure on cosmetic procedures. The growth in the geriatric population in the US and Canada is estimated to fuel the demand for facial injectables during the forecast period. In addition to this, growing consciousness about forward-looking beauty treatments and the growing emphasis on physical appearance is also projected to boost the market growth. Following North America, Asia-Pacific is anticipated to create lucrative opportunities during the forecast period. The growing beauty concerns among the adult population and the elderly population are the factors driving the facial injectable market in Asia-Pacific.

Players to Focus on Expanding Product Portfolio

The major market players operating in the market include, Advanced Dermatology, Merz, Inc., Galderma Laboratories, L.P., ColBar LifeScience Ltd., Allergan, Plc, Valeant Pharmaceuticals North America LLC, Sanofi Biosurgery Inc., and Anika Therapeutics, Inc.

Scope of the Report

By Product

• Collagen
• Hyaluronic Acid
• Botulinum Toxin Type A
• Calcium Hydroxylapatite
• Polymer Fillers

By Application

• Aesthetics
• Therapeutics

By Region

• North America
• Europe
• Asia Pacific
• SAMEA

Key Reasons to Purchase this Report

1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.